Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Banner with AIMday logo and view of delegates at an AIMday

The University of Oxford is hosting an AIMday in Women’s Health industry event on Tuesday 22 March (postponed from June 2021). This event will bring together industry with academia to discuss key challenges in women’s health.  

The AIMday format allows industry to propose challenges for one-hour roundtable discussions with groups of relevant academics and clinicians from Oxford. For academics, this is a great chance to see how your research can be applied in industry and to meet potential future collaborators. View the list of challenges put forward by industry.

Participating companies include: Ferring Pharmaceuticals, Fertility Circle, Natural Cycles, Gynica, MirZyme Therapeutics, Syrona Health, Altus Life Sciences, Cambridge Digital Health, OCON Healthcare & Endodiag.

Registration for Oxford-affiliated researchers is now open and will close on Tuesday 1 March 2022. Advance registration is essential.

Read more about the AIMday in Women's Health and register to attend.

For more details, please contact Amira Burshan, Business Engagement Facilitator, Business Partnerships Office.

Similar stories

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.

Anant Parekh to deliver The Physiological Society's Annual Review Prize Lecture

The Annual Review Prize Lecture is The Physiological Society's most prestigious lecture.

Department of Paediatrics celebrates 50-year anniversary

After being established in 1972, the Department of Paediatrics' contributions have spanned teaching, innovation, and research. The department also builds upon a longer lineage in Oxford that has impacted child health.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from UK research institutions.

Oxford expands the Cartography collaboration with Janssen

The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation

Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology

The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.